In this Q&A, Patrick Mizer, chief technology officer at Ledger Run, discusses how payment reliability has become a ...
In today's ACT Brief, we examine value hidden in the RBQM financial model, why rare disease research leads on genuine patient ...
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD discuss what the RBQM financial ...
Senior leaders reiterated that GCP expectations are geography-agnostic, and inadequate inspection access can render foreign ...
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain why time savings dominates ...
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain how combining real-world ...
Patient-centricity remains largely consultative in most clinical research, yet rare disease communities demonstrate that ...
In today's ACT Brief, we examine why many trial failures trace to human readiness gaps rather than process design alone, how ...
Static budgeting models and one-size-fits-all fair market value approaches create visibility gaps around inflation and true ...
In today's ACT Brief, we examine how eNPV modeling and real-world data finally put numbers on RBQM value, why static ...
Agentic AI is arriving in clinical operations with genuine capability to absorb administrative work, but the organizations ...
Life Sciences Digital Leader with over 15 years of experience operating at the intersection of biological domain science and digital engineering. Holding a PhD in Genomics and Bioinformatics, she ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results